1-2 of 2
Peter L. Bonate
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1

Clinical Trials & Observations
Elena Lukina, Nora Watman, Elsa Avila Arreguin, Maryam Banikazemi, Marta Dragosky, Marcelo Iastrebner, Hanna Rosenbaum, Mici Phillips, Gregory M. Pastores, Daniel I. Rosenthal, Mathilde Kaper, Tejdip Singh, Ana Cristina Puga, Peter L. Bonate, M. Judith Peterschmitt
Journal: Blood
Blood (2010) 116 (6): 893–899.
https://doi.org/10.1182/blood-2010-03-273151
Published: 2010
Journal Articles

Population Pharmacokinetics of Alemtuzumab in Patients with Hematologic Malignancies.

Peter L. Bonate, Michael Keating, Steve Weitman, Peter Hillmen, Diane R. Mould
Journal: Blood
Blood (2005) 106 (11): 2961.
https://doi.org/10.1182/blood.V106.11.2961.2961
Published: 2005